Lung cancer, Non small cell lung cancer (NSCLC)
Open
Phase 3
This trial is looking at durvalumab and domvanalimab for non small cell lung cancer that has grown into surrounding tissues.
It is for people with non small cell lung cancer that:
is
can’t be removed by surgery and
hasn’t got worse following
Recruitment start: 18 February 2022
Recruitment end: 30 September 2026
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Shobhit Baijal
AstraZeneca
Last reviewed: 15 Jun 2025
CRUK internal database number: 18641
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
